CL2004000898A1 - COMPOUNDS DERIVED FROM TRIAZOLALQUILFENILAMINA OR TRIAZOLALQUILFENILAMIDA REPLACED BY OXAZOL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND IN THE TREATMENT OF CANCER. - Google Patents
COMPOUNDS DERIVED FROM TRIAZOLALQUILFENILAMINA OR TRIAZOLALQUILFENILAMIDA REPLACED BY OXAZOL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND IN THE TREATMENT OF CANCER.Info
- Publication number
- CL2004000898A1 CL2004000898A1 CL200400898A CL2004000898A CL2004000898A1 CL 2004000898 A1 CL2004000898 A1 CL 2004000898A1 CL 200400898 A CL200400898 A CL 200400898A CL 2004000898 A CL2004000898 A CL 2004000898A CL 2004000898 A1 CL2004000898 A1 CL 2004000898A1
- Authority
- CL
- Chile
- Prior art keywords
- cancer
- pharmaceutically acceptable
- triazolalquilfenilamina
- triazolalquilfenilamida
- oxazol
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
OBJETIVOS DE LA PRESENTE INVENCION SON LOS COMPUESTOS DE FORMULA (I) SUS SALES FARMACEUTICAMENTE ACEPTABLES, ENANTIOMERICAS, DIASTEREOISOMEROS, Y RACEMATOS, LA PREPARACION DE LOS COMPUESTOS ANTERIORMENTE MENCIONADOS, MEDICAMENTOS QUE LOS CONTIENEN Y SU FABRICACION, ASI COMO EL USO DE LOS COMPUESTOS ANTERIORMENTE MENCIONADOS, EN EL CONTROL O LA PREVENCION DE ENFERMEDADES TALES COMO CANCER.OBJECTIVES OF THE PRESENT INVENTION ARE THE COMPOUNDS OF FORMULA (I) ITS PHARMACEUTICALLY ACCEPTABLE, ENANTIOMERIC, DIASTEREOISOMERAL AND RACEMATE SALES, THE PREPARATION OF THE PREVIOUSLY MENTIONED COMPOUNDS, MEDICATIONS THAT FOLLOW THEM AND THE COMPOSITION OF , IN THE CONTROL OR PREVENTION OF DISEASES SUCH AS CANCER.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03009908 | 2003-04-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2004000898A1 true CL2004000898A1 (en) | 2005-03-04 |
Family
ID=33395779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL200400898A CL2004000898A1 (en) | 2003-04-30 | 2004-04-28 | COMPOUNDS DERIVED FROM TRIAZOLALQUILFENILAMINA OR TRIAZOLALQUILFENILAMIDA REPLACED BY OXAZOL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND IN THE TREATMENT OF CANCER. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7205326B2 (en) |
| EP (1) | EP1622896B1 (en) |
| JP (1) | JP2006515347A (en) |
| KR (1) | KR100763293B1 (en) |
| CN (1) | CN100345845C (en) |
| AR (1) | AR044098A1 (en) |
| AT (1) | ATE366252T1 (en) |
| AU (1) | AU2004234060A1 (en) |
| BR (1) | BRPI0409951A (en) |
| CA (1) | CA2522809A1 (en) |
| CL (1) | CL2004000898A1 (en) |
| CO (1) | CO5640050A2 (en) |
| DE (1) | DE602004007374T2 (en) |
| ES (1) | ES2290701T3 (en) |
| MX (1) | MXPA05011671A (en) |
| NO (1) | NO20054495L (en) |
| RU (1) | RU2005137033A (en) |
| TW (1) | TW200423931A (en) |
| WO (1) | WO2004096796A1 (en) |
| ZA (1) | ZA200508694B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200612914A (en) * | 2004-03-05 | 2006-05-01 | Hoffmann La Roche | Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents |
| FR2876692B1 (en) | 2004-10-19 | 2007-02-23 | Sanofi Aventis Sa | 2-AMIDO-4-PHENYLTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
| US20060116407A1 (en) * | 2004-11-22 | 2006-06-01 | Birgit Bossenmaier | Amide derivatives |
| JP2009504586A (en) * | 2005-08-08 | 2009-02-05 | エフ．ホフマン−ラ ロシュ アーゲー | Pyrazole derivatives, their production and use as pharmaceuticals |
| CN112920133B (en) * | 2021-01-29 | 2022-09-16 | 中国医科大学 | (E) -4-methyl-2- (4- (trifluoromethyl) styryl) oxazole compound and preparation method and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0912562A1 (en) | 1996-07-19 | 1999-05-06 | Takeda Chemical Industries, Ltd. | Heterocyclic compounds, their production and use |
| PE20011178A1 (en) | 2000-04-07 | 2001-11-19 | Takeda Chemical Industries Ltd | HETEROCYCLIC COMPOUNDS AND THEIR PRODUCTION |
-
2004
- 2004-04-26 TW TW093111557A patent/TW200423931A/en unknown
- 2004-04-26 AR ARP040101415A patent/AR044098A1/en unknown
- 2004-04-28 US US10/833,721 patent/US7205326B2/en not_active Expired - Fee Related
- 2004-04-28 CL CL200400898A patent/CL2004000898A1/en unknown
- 2004-04-29 EP EP04730211A patent/EP1622896B1/en not_active Expired - Lifetime
- 2004-04-29 JP JP2006500101A patent/JP2006515347A/en active Pending
- 2004-04-29 BR BRPI0409951-6A patent/BRPI0409951A/en not_active IP Right Cessation
- 2004-04-29 MX MXPA05011671A patent/MXPA05011671A/en active IP Right Grant
- 2004-04-29 CN CNB2004800116553A patent/CN100345845C/en not_active Expired - Fee Related
- 2004-04-29 RU RU2005137033/04A patent/RU2005137033A/en not_active Application Discontinuation
- 2004-04-29 DE DE602004007374T patent/DE602004007374T2/en not_active Expired - Fee Related
- 2004-04-29 KR KR1020057020486A patent/KR100763293B1/en not_active Expired - Fee Related
- 2004-04-29 AT AT04730211T patent/ATE366252T1/en not_active IP Right Cessation
- 2004-04-29 AU AU2004234060A patent/AU2004234060A1/en not_active Abandoned
- 2004-04-29 ES ES04730211T patent/ES2290701T3/en not_active Expired - Lifetime
- 2004-04-29 WO PCT/EP2004/004520 patent/WO2004096796A1/en not_active Ceased
- 2004-04-29 CA CA002522809A patent/CA2522809A1/en not_active Abandoned
-
2005
- 2005-09-28 NO NO20054495A patent/NO20054495L/en not_active Application Discontinuation
- 2005-10-26 CO CO05109227A patent/CO5640050A2/en not_active Application Discontinuation
- 2005-10-26 ZA ZA200508694A patent/ZA200508694B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR044098A1 (en) | 2005-08-24 |
| NO20054495L (en) | 2005-11-23 |
| NO20054495D0 (en) | 2005-09-28 |
| AU2004234060A1 (en) | 2004-11-11 |
| BRPI0409951A (en) | 2006-04-25 |
| DE602004007374D1 (en) | 2007-08-16 |
| CN100345845C (en) | 2007-10-31 |
| MXPA05011671A (en) | 2005-12-15 |
| CN1780830A (en) | 2006-05-31 |
| EP1622896A1 (en) | 2006-02-08 |
| WO2004096796A1 (en) | 2004-11-11 |
| CA2522809A1 (en) | 2004-11-11 |
| KR20060006070A (en) | 2006-01-18 |
| RU2005137033A (en) | 2006-06-27 |
| EP1622896B1 (en) | 2007-07-04 |
| ES2290701T3 (en) | 2008-02-16 |
| KR100763293B1 (en) | 2007-10-04 |
| DE602004007374T2 (en) | 2008-03-20 |
| JP2006515347A (en) | 2006-05-25 |
| ZA200508694B (en) | 2007-06-27 |
| US20040254217A1 (en) | 2004-12-16 |
| CO5640050A2 (en) | 2006-05-31 |
| US7205326B2 (en) | 2007-04-17 |
| TW200423931A (en) | 2004-11-16 |
| ATE366252T1 (en) | 2007-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR063628A1 (en) | USEFUL PIRIDINONE COMPOUNDS FOR CANCER TREATMENT | |
| CL2004000732A1 (en) | COMPOUNDS DERIVED FROM REPLACED OXIMES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS; PROCEDURE FOR PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM; AND USE OF COMPOUNDS FOR THE TREATMENT OF CANCER. | |
| BRPI0720551A2 (en) | compound or a pharmaceutically acceptable salt thereof, and, use thereof, method for treating cancer, processes for preparing a pharmaceutical composition and a compound or a pharmaceutically acceptable salt thereof | |
| UY28691A1 (en) | DERIVATIVES OF DIFENILAZETIDONA | |
| ECSP109934A (en) | COMPOUND - 946 | |
| EP2400847A4 (en) | SPECIFIC DIARYLHYDANTOIN AND DIARYLTHIOHYDANTOIN COMPOUNDS | |
| MX2020011868A (en) | ERBB RECEPTOR INHIBITORS. | |
| ECSP066302A (en) | OMEGA-CARBOXIARIL-DIFENIL-UREA REPLACED WITH FLUORINE FOR THE TREATMENT AND PREVENTION OF DISEASES AND AFFECTIONS | |
| UY28333A1 (en) | CASPASA INHIBITORS AND THEIR USES. | |
| CR8919A (en) | TETRAPEPTIDE ANALOGS | |
| MX379530B (en) | Muscarinic agonists | |
| DK1519724T3 (en) | Fredericamycin derivatives as drugs for the treatment of tumors | |
| NI201100076A (en) | THERAPEUTIC ANTIVIRAL PEPTIDES. | |
| UY31384A1 (en) | NEW HETEROCICLIC COMPOUNDS FOR THE INHIBITION OF PROTEIN KINASE B | |
| MX2022004451A (en) | HETEROARYL-BIPHENYL-AMIDES FOR THE TREATMENT OF DISEASES RELATED TO THE PD-L1 LIGAND. | |
| ECSP045353A (en) | DERIVATIVES OF BENZOXAZINONA, ITS PREPARATION AND APPLICATION AS MEDICATIONS | |
| CY1111977T1 (en) | PEPERIDIN-4-YL-PYRIDAZIN-3-YLAMINE DERIVATIVES AS HIGHLY DISTRIBUTED DOPAMIN COMPONENTS 2 | |
| UY30282A1 (en) | CHEMICAL COMPOUNDS | |
| UY28695A1 (en) | DERIVATIVES OF DIFENILAZETIDONA | |
| CR10304A (en) | TETRAHYDROPIRIDOTIENOPIRIMIDINE COMPOUNDS AND PROCEDURES FOR THE SAME USE | |
| UY30723A1 (en) | SUBSTITUTED BICICLOCARBOXYAMIDE COMPOUNDS | |
| UY30377A1 (en) | FUSIONATED TRICYCLE INHIBITORS OF SULFONAMIDE OF GAMA-SECRETASA | |
| CY1113759T1 (en) | HIGHLY DISTRIBUTED DOPAMINE COMPETITORS 2 | |
| UY29614A1 (en) | CHEMICAL COMPOUNDS | |
| BRPI0618479A2 (en) | pyrrolpyridines pharmaceutical composition containing them |